Telephone-Based Acceptance and Commitment Therapy for Young Adult Hazardous Drinkers
13. august 2026 oppdatert av: Dr Katherine Lam, The Hong Kong Polytechnic University
A Randomized Controlled Trial of Telephone-Based Acceptance and Commitment Therapy to Assist Young Adults With Hazardous or Harmful Alcohol Use to Quit Drinking
The goal of this clinical trial is to learn if telephone-based Acceptance and Commitment Therapy (ACT) works to help young adults with hazardous or harmful alcohol use quit drinking. It will also learn about the psychological effects of ACT on participants.
The main questions it aims to answer are:
- Does telephone-based ACT increase the number of participants who quit drinking, as confirmed by a urine test?
- Does telephone-based ACT help participants reduce their alcohol consumption and improve their psychological flexibility?
Researchers will compare telephone-based ACT to a telephone-based social support programme to see if ACT works to help young adults quit drinking.
Participants will:
- Receive telephone-based ACT or social support once a week for 6 weeks Complete questionnaires about their alcohol use and psychological flexibility.
- Keep a record of their daily alcohol consumption throughout the study using a standardised diary method.
- Provide a urine sample at the 6-month follow-up if they report having quit drinking
Studieoversikt
Status
Har ikke rekruttert ennå
Studietype
Intervensjonell
Registrering (Antatt)
288
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Ka Wai Katherine LAM, Doctor of Philosophy
- Telefonnummer: +852 27666420
- E-post: kw-katherine.lam@polyu.edu.hk
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- (1) aged 18-35 years
- (2) able to read Chinese and speak Cantonese
- (3) have AUDIT scores ≥ 8
Exclusion Criteria:
- (1) currently receiving other behavioural therapies for drinking
- (2) has serious mental illnesses, defined as a Kessler Psychological Distress Scale score ≥ 13
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Telephone-Based ACT Intervention
Telephone-based Acceptance and Commitment Therapy for participants
|
Participants in the intervention group will receive six weekly telephone sessions of ACT (45-60 min each) from interventionist.
|
|
Annen: Waitlist control with Telephone-Based Social Support
|
Participants in the control group will receive six weekly telephone sessions of social support (45 min each) from interventionist.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Biochemically-Validated Abstinence
Tidsramme: T4 (6 months after the end of the intervention)
|
Participants who self-report quitting drinking in the past 30 days are tested for ethyl glucuronide (a by-product of alcohol metabolism) via urine strips to confirm abstinence biochemically.
|
T4 (6 months after the end of the intervention)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-Reported 30-Day Abstinence
Tidsramme: T0 (baseline), T1 (immediately after completion of the 6-week intervention), T2 (1 month after completing the intervention), T3 (3 months after completing the intervention), T4 (6 months after completing the intervention)
|
Reduction in alcohol consumption and self-reported 30-day abstinence will be recorded using TLFB.
Participants will be asked to report the number of drinks they have consumed within the past 30 days.
|
T0 (baseline), T1 (immediately after completion of the 6-week intervention), T2 (1 month after completing the intervention), T3 (3 months after completing the intervention), T4 (6 months after completing the intervention)
|
|
Reduction in Alcohol Consumption
Tidsramme: T1 (immediately after completion of the 6-week intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)
|
Defined as 50% or more reduction in average alcohol consumption per day compared to baseline, measured using the Timeline Follow-Back (TLFB) questionnaire.
|
T1 (immediately after completion of the 6-week intervention), T2 (1 month after the intervention), T3 (3 months after the intervention), T4 (6 months after the intervention)
|
|
Psychological Flexibility Index
Tidsramme: T0 (baseline), T1 (immediately after completion of the 6-week intervention), T2 (1 month after completing the intervention), T3 (3 months after completing the intervention), T4 (6 months after completing the intervention)
|
Personalised Psychological Flexibility Index(PPFI) will be used to measure psychological flexibility by 19 items rating on a 7-point scale.
Higher scores represent greater psychological flexibility.
It has been validated among Chinese college students
|
T0 (baseline), T1 (immediately after completion of the 6-week intervention), T2 (1 month after completing the intervention), T3 (3 months after completing the intervention), T4 (6 months after completing the intervention)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. august 2026
Primær fullføring (Antatt)
31. juli 2029
Studiet fullført (Antatt)
31. juli 2029
Datoer for studieregistrering
Først innsendt
26. mai 2026
Først innsendt som oppfylte QC-kriteriene
26. mai 2026
Først lagt ut (Faktiske)
2. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
17. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
13. august 2026
Sist bekreftet
1. august 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- ACT Alcohol
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .